USE OF CARRIMYCIN OR ITS ACTIVE INGREDIENTS Russian patent published in 2022 - IPC A61K31/7048 A61P25/28 A61P3/10 A61P43/00 

FIELD: medicine.

SUBSTANCE: group of inventions relates to the field of medicine; it is intended for the use of a drug for the treatment of Alzheimer’s disease, while the drug contains the first active ingredient, which in turn includes carrimycin, while the dose of the first active ingredient of the drug varies from 10 to 1500 mg/kg. The group of inventions also relates to the use of a drug for the treatment of diabetes and to the use of a drug to increase life expectancy.

EFFECT: positive effect on resistance to senilism, diabetes or Alzheimer’s disease, which provides a theoretical justification for the clinical use of medicinal substance, carrimycin, or its active medicinal ingredients, as well as important economic and social beneficial effects.

18 cl, 8 tbl, 9 ex, 16 dwg